ACTABIO ApS: Financial statements 2025
CVR: 26025338
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ACTABIO ApS (CVR 26025338) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 12,375 and a net result of DKK -80,533 compared with DKK -76,814 the year before. The profit margin was -650.8%. Equity in the 2025 report amounted to DKK -396,968.
- Revenue
- DKK 12,375
- Gross Profit
- DKK -47,652
- Profit/Loss
- DKK -80,533
- Equity
- DKK -396,968
- Total Assets
- DKK 13,698
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 12 t. | -48 t. | -81 t. | -397 t. | - |
| 2024 | 0 | -49 t. | -77 t. | -316 t. | - |
| 2023 | 64 t. | 27 t. | -57 t. | -240 t. | - |
| 2022 | 22 t. | -22 t. | -92 t. | -182 t. | - |
| 2021 | 87 t. | 28 t. | -30 t. | -90 t. | - |
Official annual report
How creditworthy is ACTABIO ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ACTABIO ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -76,814.
About ACTABIO ApS
ACTABIO ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Finn Thyge Okkels. The company is owned by Finn Thyge Okkels. The company has 0 employees (2018). In 2025, the company reported revenue of DKK 12,375 and a net result of DKK -80,533 compared with DKK -76,814 the year before. Equity in the 2025 report amounted to DKK -396,968.